(Q34447626)

2 August 2017

title

Effect of labetalol on limb haemodynamics in patients following coronary artery bypass graft surgery (English)

1 reference

coronary artery bypass surgery

2 August 2017

0 references

0 references

1 reference

Halperin JL

1

1 reference

2 August 2017

Mindich BP

2

1 reference

2 August 2017

Rothlauf EB

3

1 reference

2 August 2017

Reder RF

4

1 reference

2 August 2017

Litwak RS

5

1 reference

2 August 2017

Kupersmith J

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

537-542

1 reference

Immediate haemodynamic and metabolic effects of intravenous labetalol in the exercising forearm.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Direct vasodilatation by labetalol in anaesthetized dogs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Labetalol. Current research and therapeutic status

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Haemodynamic and metabolic effects of combined adrenergic alpha- and beta-receptor blockade with labetalol in the exercising human forearm.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Alpha-Adrenergic Receptor Subtypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Hemodynamics of postmyocardial revascularization hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: Labetalol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Labetalol: a review of its pharmacology and therapeutic use in hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401022

Pharmacology of labetalol in experimental animals

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02839.X

Systemic arterial hypertension associated with cardiac surgery.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02839.X

Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02839.X

Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2872908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of acute oral beta adrenergic blockade on muscle blood flow in man

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2872908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Labetalol: an alpha- and beta-adrenoceptor blocking drug

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2872908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1986.TB02839.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference